Hattori, S. (2018). Anti-inflammatory effects of empagliflozin in patients with type 2 diabetes and insulin resistance. Diabetol Metab Syndr.
Citação norma ChicagoHattori, Sachiko. "Anti-inflammatory Effects of Empagliflozin in Patients With Type 2 Diabetes and Insulin Resistance." Diabetol Metab Syndr 2018.
MLA CitationHattori, Sachiko. "Anti-inflammatory Effects of Empagliflozin in Patients With Type 2 Diabetes and Insulin Resistance." Diabetol Metab Syndr 2018.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.